Retatrutide, a experimental dual stimulator of the GLP-1 binding site and glucose-dependent secreted polypeptide (GIP) binding site , is showing promising outcomes in preliminary patient studies. https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/